Características
The DKMS John Hansen Research Grant is funding provides finding for the research into hematopoietic stem cell transplantation and cell therapy for hematological diseases. The application period for the 2027 grant is now open.
The DKMS John Hansen Research Grant supports promising young scientists conducting research in the field of blood cancer, with a particular focus on hematopoietic stem cell transplantation and cell therapy for hematological diseases. Projects primarily focused on product development, commercialization or other commercial activities are not eligible.
The grant can cover, among other things, consumables, the PI’s own position, a PhD student dedicated to the project, technicians working at least 30% of their time on the project, relevant training, and certain publication costs. Up to EUR 2,500 per year can be used for travel, accommodation and registration fees for a scientific meeting to present project results. and up to EUR 10,000 may be included for reasonable publication costs, including open-access fees.
The duration of the grant is up to 3 years. Each annual funding period runs from 1 July to 30 June of the following year. The funding is up to EUR 240,000, with a maximum of EUR 80,000 per year.
Requisitos:
- Applicants from all countries are welcome to apply.
- Applicants must have obtained a doctoral degree (PhD, MD or equivalent) in a field relevant to the grant within the 10 years preceding the start of the call.
- Applicants must appoint a supervisor, ideally a senior scientist at the host institution with expertise relevant to the proposed research.
Cómo se solicita
Applicants must submit:
- information about the applicant;
- a description of the research project; and
- a budget plan, following the Application Instructions.
Applications must be submitted via email to grant@dkms.org until November 16, 2026, 23:59h (Central European Time).